Cardiomyopathy

Welcome to our featured section on cardiomyopathy

This educational hub pulls together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub will be CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos.

See more ▼
Close X
Other videos you might like

Section Advisor

Professor Perry Elliott

Chair, Cardiovascular Medicine, University College London, and Head, Clinical Research, UCL Institute of Cardiovascular Science, London, UK

Supported through an educational grant from Bristol Myers Squibb.

Video Series

e-SPACE CRM 2022

Andrew JS Coats, Stefan Anker,

Video Series

e-SPACE Heart Failure 2021

Lars H Lund, James L Januzzi, Justin Ezekowitz, et al

Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Video

Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Martin S Maron,

Recent Videos

Video Series

e-SPACE CRM 2022

Andrew JS Coats, Stefan Anker,

ACC 22: Mavacamten in Patients with Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Video

ACC 22: Findings from the VALOR-HCM Trial

Milind Y Desai,

Video Series

e-SPACE Heart Failure 2021

Lars H Lund, James L Januzzi, Justin Ezekowitz, et al

Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Video

Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Martin S Maron,

ESC 2020: Commentary on the EXPLORER-HCM Study

Video

ESC 2020: Commentary on the EXPLORER-HCM Study

Giuseppe Galati,